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Ectoine is a compatible water molecule-binding solute (osmoprotectant) produced by several bacterial species in response 
to osmotic stress and unfavourable environmental conditions. This amino acid derivative can accumulate inside cells at 
high concentrations without interfering with natural processes and can protect the cell against radiation or osmotic stress. 
This brief review presents the current state of knowledge about the effects of ectoine on animals and focuses on its practical 
use for enzyme stabilisation, human skin protection, anti-inflammatory treatment, inhibitory effects in neurodegenerative 
diseases, and other therapeutic potential in human or veterinary medicine.
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Various organisms have developed different mechanisms 
to protect themselves against stress caused by environmental 
factors such as drought or extreme temperatures. Bacteria, 
especially those living in extreme environments, have the 
ability to produce compounds of small molecular weight 
known as compatible solutes or osmoprotectants, which do 
not interfere with cellular processes. They can accumulate 
to high concentrations and prevent cell dehydration (1). 
According to the structure, compatible solutes belong to 
the following groups: sugars (sucrose, trehalose), polyols 
(sorbitol, glycerol, mannitol, mannosyl-glyceramide, 
mannosyl-glycerol), N-acetylated diamino acids 
(N-acetylglutaminylglutamine amide), betaines (betaine, 
glycine, and deritatives), and amino acids and derivatives 
(proline, glutamate, glutamine, alanine, ectoine, and 
hydroxyectoine).
These substances strongly bind water molecules and 
stabilise macromolecules. Although their mechanism of 
action is not entirely known, there are several hypotheses 
explaining biophysical principles by which they act. The 
most widely accepted hypothesis is the “preferential 
exclusion model”, according to which osmoprotectants do 
not interact directly with the macromolecule in an aqueous 
solution but are repelled to the bulk region, increasing 
macromolecule’s hydration and thereby preventing its 
denaturation (2-4).
Ectoine (1,4,5,6-tetrahydro-2-methyl-4-pyrimidine 
carboxylic acid; for structure see Figure 1a) is a water-
binding zwitterionic amino acid derivative (142,156 Da), 
first isolated from Ectothiorhodospira halochloris (5). It is 
also produced and accumulated by other, mainly aerobic, 
chemoheterotrophic and halophilic bacteria, such as alpha- 
and gammaproteobacteria and Actinobacteridae, in which 
it stabilises cell membranes, enzymes, and nucleic acids at 
extreme temperatures or higher salt concentrations (6). 
Ectoine synthesis from its precursor, L-aspartate-β-
semialdehyde is catalysed by ectoine ABC enzymes, 
including diaminobutyric acid (DABA) acetyltransferase 
(ectA), DABA aminotransferase (ectB), and ectoine 
synthase (ectC) (7). Genes encoding these enzymes are 
organised in either ectABC or ectABC-ask operons (8).
A number of biophysical studies show that ectoine binds 
water molecules even better than some other osmoprotectants 
such as glycerol (9, 10) and that it is well tolerated by 
humans, animals, and various cell cultures. In fact, ectoine 
retains strong hydration properties even at high NaCl 
concentrations (11).
The aim of this brief review is to present the current 
state of knowledge about the effects of ectoine on animals 
and discuss its practical use in enzyme stabilisation, human 
skin protection, anti-inflammatory treatment, prevention of 
neurodegenerative diseases, and other therapeutic potentials 
in human or veterinary medicine.
Skin protection
Ectoine has widely been used in cosmetic anti-ageing 
and moisturising creams to improve skin resistance to 
surfactants in skin cleansing solutions (12). It is an effective 
long-term moisturiser that prevents dehydration of the 
epidermis, even superior to the well-known membrane 
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stabiliser phosphatidylcholine. Some authors suggest that 
at relatively low concentrations (up to 500 µmol L-1) it can 
also be used as a whitening agent because of its inhibitory 
effect on melanin synthesis in B16-F0 and A2058 melanoma 
cell lines and on mushroom and cellular tyrosinase activities 
(13). Ectoine also alleviates skin inflammation and is 
currently recommended for the treatment of moderate atopic 
dermatitis (14).
In addition, ectoine strongly absorbs ultraviolet (UV) 
radiation and protects DNA from breaking down in various 
cell types (15; 16). Grether-Beck et al. (17) reported that 
ectoine reduced UV-A-induced ceramide signalling 
response in human keratinocytes, while Buenger et al. (16) 
reported protective effects against UV radiation in 
immunocytes and Langerhans cells.
Stabilising enzyme activity
A number of studies have indicated that ectoine 
increases the stability of enzymes maintaining hydration 
and thereby reducing protein susceptibility to denaturation. 
Interestingly, this amino acid derivative does not interact 
directly with protein surfaces but rather it forms a molecular 
net holding water molecules close to the macromolecule 
(10, 18, 19). Moreover, Roychoudhury et al. (20) have 
shown that ectoine, like other compatible solutes, 
strengthens intramolecular interactions essential for protein 
stability. Ectoine reduces denaturation of enzymes induced 
by a rapid change of temperature. It prolongs the activity 
of lactate dehydrogenase (LDH) and phosphofructokinase, 
enzymes that are normally sensitive to freeze-thawing, 
heating, and freeze-drying (21). It also increases the stability 
of phytase, ribonuclease-A, and polymerase of the double-
stranded DNA at elevated temperature (22, 23).
Tenne et al. (24) found that ectoine derivative 
hydroxyectoine (for structure see Figure 1b) is even superior 
to ectoine in protecting against elevated temperatures.
Ectoine has also been reported to protect macromolecules 
against proteolytic agents. For example, zymogens 
chymotrypsinogen and trypsinogen were resistant to 
proteolysis by enteropeptidases (25). Another study showed 
that antibodies treated with ectoine were less susceptible 
to proteolytic degradation by pepsin (26).
In addition, ectoine can inhibit HIV replication (23) and 
can also stabilise retroviral vectors for gene therapy, which 
may be a useful property, because these vectors usually lose 
their infectivity during long-term storage and transport (27).
Cell protection
Various environmental stressors such as heat or toxic 
chemicals may impair the cell membrane function and result 
in cell dehydration and denaturation. Harishchandra et al. 
(28) propose that ectoine increases cell membrane fluidity 
to cope with extreme conditions such as high temperature 
or osmotic pressure. A recent biophysical study by Zacchai 
et al. (10) showed that ectoine is excluded from the 
hydration layer at the membrane surface and does not affect 
membrane molecular dynamics. Moreover, improved 
hydration of the cell surface thanks to ectoine increases 
intermolecular spacing and boosts the mobility of the lipid 
head groups in the cell membrane (Figure 2) (29).
Different types of cells subjected to high temperature 
tend to produce chaperone proteins such as heat shock 
proteins (Hsp), which repair misfolded peptides. Ectoine 
seems to affect their synthesis and is speculated to act as a 
chaperone molecule itself (30). Buommino et al. (31) 
reported that heat-stressed keratinocytes incubated with 
ectoine had higher levels of Hsp70 and inhibited the 
production of pro-inflammatory signals.
Some studies indicate that ectoine shows promising 
properties against the detrimental effects of some toxic 
compounds. In a study by Graf et al. (12) ectoine-treated 
human erythrocytes were more resistant to membrane-
damaging sodium dodecyl sulphate detergent than untreated 
cells. Our recent study (32) has shown that ectoine has a 
potential to block pore-forming toxins, as the isolated 
bovine erythrocytes treated with ectoine turned out to be 
less sensitive to staphylococcal alpha-haemolysin. 
Interestingly, the toxin monomers preincubated with ectoine 
were less cytotoxic than those added to the cell suspension 
simultaneously with ectoine, which suggests that ectoine 
blocks the unfolding of the toxin monomers and thus 
prevents the formation of transmembrane pores in the cell 
membrane. These findings suggest that ectoine may be 
useful in protecting erythrocytes from staphylococcal 
haemolysins. Little is known, however, about ectoine 
protective effects against toxins produced by other bacterial 
species, mycotoxins, and toxic proteins found in animal 
venom. Future research should answer whether the 
osmoprotectant could be an effective antidote.
Alleviation of inflammatory reaction
Ectoine effectively alleviates inflammation, such as the 
experimentally induced colitis in rats (33) or nanoparticle-
induced neutrophilic lung inflammation (34). It can also 
mitigate inflammatory reactions in the lung epithelial cells 
after inhalation of carbonaceous nanoparticles in mice. 
However, this effect was not observed when lung 
inflammation was induced by bacterial lipopolysaccharide 
(35). Peuschel et al. (36) reported that inhalational exposure 
Figure 1 Structural variants: ectoine (a) and hydroxyectoine (b)
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to carbon nanoparticles in mice resulted in the accumulation 
of ceramides in lipid rafts of cell membranes, activation of 
epidermal growth factor receptor (EGFR), and lung 
inflammation. Animals additionally treated with ectoine, 
however, showed milder allergic reactions because ectoine 
seems to have inhibited ceramide-mediated EGFR 
phosphorylation. Another study showed that ectoine and 
hydroxyectoine enhance lung surfactants, which suggests 
their potential use as supporting factors in inhalation therapy 
(37).
Ectoine was also found to protect ileal mucosa against 
ischaemia and reperfusion injury, which are common 
complications after the small bowel transplantation (38, 
39). Alleviating the inflammatory reaction is related to the 
improvement of intestinal barrier and reduction of cytokine 
production (33).
Nasal spray and air drops containing ectoine are the 
new approaches  to  t rea t ing  a l le rg ic  rh in i t i s , 
rhinoconjunctivitis, and dry eye syndrome (29). Some 
studies showed that products containing ectoine may be a 
better alternative to other products, as they reduce ocular 
and nasal symptoms with no side effects (40-42). Promising 
effects such as reduction of nasal airway obstruction and 
crust formation were also observed in patients with rhinitis 
sicca anterior treated with nasal spray containing ectoine 
alone or in combination with dexpanthenol (43). Moreover, 
a recent study has shown that a mouth and throat spray 
containing ectoine can be very effective in the treatment of 
acute pharyngitis and laryngitis (44).
Cryoprotection
Compatible solutes such as ectoine and hydroxyectoine 
are effective agents in cryopreservation. Bissoyi and 
Pramanik (45) reported it to be an efficient additive in 
cryoprotective media for mononuclear cells isolated from 
human umbilical cord blood. Their 10 % foetal bovine 
serum medium containing a combination of hydroxyl ethyl 
starch, ectoine, and co-enzyme Q10 yielded the highest, 
93 % viability of mononuclear cells. Sun et al. (46) reported 
that both ectoine and hydroxyectoine protected human 
endothelial cell line HPMEC-ST1.6R or mesenchymal stem 
cells and suggested that they may be used in cryobiology 
as an alternative to the toxic dimethyl sulphoxide (DMSO). 
One study on rats (47) showed that adding hydroxyectoine 
to the histidine-tryptophan-ketoglutarate solution reduces 
the cold ischaemic preservation injury of livers donated 
after cardiac death and used for transplantation. Ectoine 
was also successfully used as a cryoprotectant of human 
erythrocytes, as it prevented slow-freezing cell damage 
(48).
Protection against neurodegenerative diseases
Some pathological processes like amyloid formation 
and aggregation induce neurodegenerative diseases. Ectoine 
was found to prevent amyloid formation and delay the onset 
and progression of Alzheimer’s disease (49). Other studies 
have shown that this amino acid derivative inhibits insulin 
amyloid formation and interacts with prion aggregation 
responsible for transmissible spongiform encephalopathies 
(50-52).
Protection of invertebrates against environmental 
stressors
Little is known about how ectoine acts in invertebrates. 
In our earlier studies (53-55) ectoine showed protective 
effects in Daphnia magna subjected to high temperature 
by inhibiting heat shock protein Hsp70, catalase activity, 
and NO radicals. Moreover, ectoine-treated Daphnia magna 
were more resistant to toxic disinfectants formaldehyde and 
hydrogen peroxide than untreated controls, as manifested 
through significantly lower mortality rates, better swimming 
activity, and better physiological parameters such as heart 
rate and thoracic limb activity (56). In practice, it could be 
used as a stabilising agent during the transport of some 
edible species sensitive to different forms of stress.
CONCLUSION
As ectoine is a potent protective agent against different 
forms of stress without toxic side effects, its current use in 
biotechnology, cosmetics, and medicine, leaves a lot of room 
for many innovative applications. However, since the reviewed 
literature covers a wide range of studies of different complexity, 
from isolated macromolecules and cell cultures to various 
animal species, the protective effects of ectoine observed in 
simple systems may fail in more complex ones. Moreover, 
ectoine inactivates some molecules; therefore its use may be 
limited due to possible interactions with other pharmaceuticals.
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Obećavajuća zaštitna svojstva ektoina u ljudi i životinja
Ektoin je kompatibilni osmolit (osmoprotektant) koji proizvodi više bakterijskih vrsta kao odgovor na osmotski stres i 
nepovoljne uvjete u okolišu. Ovaj se derivat aminokiseline može nakupiti i dosegnuti visoke razine u samoj stanici a da 
pritom ne ometa prirodne stanične procese. Usto štiti stanicu od zračenja ili osmotskoga stresa. Svrha je ovoga članka 
dati kratak pregled dosadašnjih spoznaja o djelovanju ektoina u životinja, s posebnim osvrtom na praktičnu primjenu 
ovoga osmoprotektanta u stabilizaciji enzima, zaštiti kože u ljudi, protuupalnoga liječenja, sprječavanja ili usporavanja 
neurodegenerativnih bolesti te u ostalim oblicima liječenja ljudi i životinja.
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